Regeneron Pharmaceuticals Inc Stock Price Target Increased by Analysts
Regeneron Pharmaceuticals Inc has seen a significant increase in its stock price target from various analysts following better-than-expected earnings.
- RBC Capital and Morgan Stanley have increased their price targets for the company.
- BMO Capital and Guggenheim have also raised their estimates.
These developments suggest a positive outlook for the company, with analysts expecting its stock to perform well despite regulatory challenges.
The company’s stock price is expected to rise as a result of these increased forecasts, although the exact magnitude of this increase is not specified.
Analysts Who Raised Their Forecasts
- RBC Capital
- Morgan Stanley
- BMO Capital
- Guggenheim